Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents

  1. Edson X. Albuquerque*,,
  2. Edna F. R. Pereira*,
  3. Yasco Aracava*,
  4. William P. Fawcett*,
  5. Maristela Oliveira*,
  6. William R. Randall*,
  7. Tracey A. Hamilton,
  8. Robert K. Kan,
  9. James A. Romano, Jr.§, and
  10. Michael Adler
  1. *Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201;
  2. Comparative Pathology Branch and
  3. Neurobehavioral Toxicology Branch, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010; and
  4. §U.S. Army Medical Research and Materiel Command, Fort Detrick, MD 21702
  1. Communicated by John W. Daly, National Institutes of Health, Bethesda, MD, June 28, 2006 (received for review May 24, 2006)

Abstract

The nerve agents soman, sarin, VX, and tabun are deadly organophosphorus (OP) compounds chemically related to OP insecticides. Most of their acute toxicity results from the irreversible inhibition of acetylcholinesterase (AChE), the enzyme that inactivates the neurotransmitter acetylcholine. The limitations of available therapies against OP poisoning are well recognized, and more effective antidotes are needed. Here, we demonstrate that galantamine, a reversible and centrally acting AChE inhibitor approved for treatment of mild to moderate Alzheimer’s disease, protects guinea pigs from the acute toxicity of lethal doses of the nerve agents soman and sarin, and of paraoxon, the active metabolite of the insecticide parathion. In combination with atropine, a single dose of galantamine administered before or soon after acute exposure to lethal doses of soman, sarin, or paraoxon effectively and safely counteracted their toxicity. Doses of galantamine needed to protect guinea pigs fully against the lethality of OPs were well tolerated. In preventing the lethality of nerve agents, galantamine was far more effective than pyridostigmine, a peripherally acting AChE inhibitor, and it was less toxic than huperzine, a centrally acting AChE inhibitor. Thus, a galantamine-based therapy emerges as an effective and safe countermeasure against OP poisoning.

Footnotes

  • To whom correspondence should be addressed. E-mail: ealbuque{at}umaryland.edu
  • Author contributions: E.X.A., E.F.R.P., J.A.R., and M.A. designed research; E.X.A., E.F.R.P., Y.A., W.P.F., M.O., W.R.R., T.A.H., and R.K.K. performed research; E.X.A., E.F.R.P., Y.A., W.P.F., W.R.R., and R.K.K. analyzed data; and E.X.A. and E.F.R.P. wrote the paper.

  • Conflict of interest statement: No conflicts declared.

  • Abbreviations:
    AChE,
    acetylcholinesterase;
    BuChE,
    butyrylcholinesterase;
    FJ-B,
    Fluoro-Jade B;
    OP,
    organophosphorus
  • Freely available online through the PNAS open access option.

« Previous | Next Article »Table of Contents
OPEN ACCESS ARTICLE